InvestorsHub Logo

Rollgard1

10/01/21 6:44 AM

#3294 RE: ShortsRClowns #3292

Merk's drug only shows a 50% efficacy rate....

per news today.However it being the first of it's kind and study results being released first gets the "first Praise"....Wait until Tempol results are know, Interim analysis and we will see what ADMP's TEMPOL looks like for efficacy....

Safety profile is there as well as 2300 papers written on Tempol..


Tic Toc..Geesh 50% efficacy...LOWER THAN THE VACCINES RATES!! ALL OF THEM..

Pom Pom not needed for 50% rate...jmho...GO ADMP>............

https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/